WuXi XDC’s Post

🎯 Webinar Alert: Accelerating ADC Drug Development 🎯 ADCs are revolutionizing therapy for life-threatening diseases, but their development comes with significant challenges. The complexity of combining large and small molecules, and the need for multiple manufacturing processes, slows progress. Tackling these issues requires advanced CMC expertise and innovative technologies to streamline development and expedite approval. 🌟 Key Focus Areas: • Overcoming ADC development hurdles. • Accelerating CMC for IND and BLA. • Real-world case studies. Learn more strategies to accelerate ADC development! #ADC #DrugDevelopment #CMC #Biotech #Pharma

📣 Last minute to register the insightful webinar "Accelerating ADC Drug Development with Technology Innovation and Integrated Platform". During this session, Dr. Bingquan (Stuart) Wang, a Senior Director of US-EU CMC Management at WuXi XDC with extensive CMC experiences in ADC and bioconjugation field, will delve into how to overcome hurdles with advanced CMC expertise and innovative technologies.   Key Takeaways: 💡 Facing main challenges across the ADC field. 💡 Learning strategies to overcome these challenges. 💡 Discovering how to accelerate CMC development for IND. 💡 Understanding strategies to accelerate BLA development. 💡 Analyzing case studies.   Find more info and to register for this webinar: https://lnkd.in/gRi7qUzV

Join us on Thursday, Sep.26th at 10AM EST for a webinar on "Accelerating ADC Drug Development with Technology Innovation and Integrated Platform". During this session, Dr. Bingquan (Stuart) Wang, a Senior Director of US-EU CMC Management at WuXi XDC with extensive CMC experiences in ADC and bioconjugation field, will delve into how to overcome hurdles with advanced CMC expertise and innovative technologies. Key Takeaways: 💡 Facing main challenges across the ADC field. 💡 Learning strategies to overcome these challenges. 💡 Discovering how to accelerate CMC development for IND. 💡 Understanding strategies to accelerate BLA development. 💡 Analyzing case studies. Register for this webinar: https://lnkd.in/gRi7qUzV

Join us on March 6th at the IFPAC Annual Meeting from 8:40 AM to 9:05 AM, where our esteemed speaker, Farshid Mohammadparast, Scientist IV, will unravel the transformative journey of USP in embracing cutting-edge Process Analytical Technology (PAT) capabilities. More specifically, he'll cover: 💡 Strategic PAT Implementation: USP integration of state-of-the-art benchtop spectroscopic instruments into its laboratories. ⚙️ Revolutionizing Continuous Manufacturing (CM): Our advanced flow reactor for continuous synthesis of key active pharmaceutical ingredients showcases our commitment to pushing manufacturing boundaries. 🔍 Real-time Monitoring & Control: PAT optimizes processes, enhances product quality, and increases yield for greater efficiency and excellence. 🌐 Public Health Alignment: PAT and CM focus aligns with USP priorities, enhancing medicine supply chain resilience. Join us at the forefront of innovation and be part of the transformative conversation. Let's shape the future of pharmaceuticals together! #PATInnovation #ContinuousManufacturing #USPAdvancements #HealthcareRevolution

🚀 Introducing Dr. Dawaye A Georgewill, Ph.D.: ARSI Canada’s Lead Consultant for Formulation & Process Development! We’re thrilled to welcome Dr. Georgewill to the ARSI team! With 25+ years in formulation and process development, he specializes in scaling solid and semi-solid dosage forms from lab to commercial scale. His expertise will help our clients achieve efficient, high-quality solutions tailored to their unique development challenges. Here’s how Dr. Georgewill and our consulting team can support your drug development journey: ✅ IP Evaluation: Navigate commercialization smoothly with IP and freedom-to-operate (FTO) analyses. ✅ R&D Formulation: Custom solutions to optimize stability, bioavailability, and delivery. ✅ Process Development: Scalable processes from lab to pilot scale, including specialized techniques like spray-drying. ✅ Pivotal Batch Scale-Up: Ready-to-submit exhibit batches for regulatory success. ARSI Canada’s consulting services are designed to meet the needs of biotech, pharma, academia, and specialty chemical industries. Whether overcoming early-stage challenges or preparing for commercial production, we’re here to help you succeed. 🌍 Curious to learn how we can support your goals? Discover our consulting services here: https://lnkd.in/g-KbbDZk Let’s turn your challenges into achievements together! 💼💡 #FormulationDevelopment #ProcessDevelopment #DrugDevelopment

Deep dive into Quality by Design (QbD) with Evotec’s upcoming webinar: ‘Application of Design of Experiments in API Chemical Development’ Our API Research expert, Francesco Tinazzi, will explain the application of Design of Experiments (DoE) to chemical processes during API development, uncovering its advantages over traditional methods. Discover how DoE can be planned, with the identification of factors affecting the outputs, along with case studies that highlight the real-world benefits and applications of DoE in API development. Register now for the presentation and live Q&A, and discover the full series on QbD and DoE in drug development: https://hubs.ly/Q02tzxW20 #researchneverstops #drugdevelopment #QualityByDesign

'Design and Conduct of Bioequivalence Studies' workshop is coming up. The main objective of this 3-day workshop is to provide an up-to-date overview of bioequivalence testing, focusing on the scientific, industrial as well as regulatory perspectives. It will cover planning, conduct, analysis and reporting bioequivalence studies according to current regulatory requirements. The course will also touch on the physicochemical and formulation factors that affect drug bioavailability and bioequivalence during the drug development process. The following topics will be covered: - Study Protocol (Planning and Conduct of BE Studies) - Clinical Study Procedures - Analytical Study Procedures - Evaluation of BE Studies and Reporting Registration link: https://lnkd.in/dkkMHQtP

🔬 Exciting Opportunity Alert! Join Our Workshop on Design and Conduct of Bioequivalence Studies! 🔬 Are you ready to deepen your understanding of bioequivalence testing? Don't miss out on our upcoming 3-day workshop designed to provide a comprehensive overview of bioequivalence studies from scientific, industrial, and regulatory perspectives. Gain insights into planning, conducting, analyzing, and reporting bioequivalence studies. 🔍 Workshop Topics Include: 1️⃣ Study Protocol. 2️⃣ Clinical Study Procedures. 3️⃣ Analytical Study Procedures. 4️⃣ Evaluation of BE Studies and Reporting. 💡 Whether you're a researcher, pharmaceutical professional, or regulatory expert, this workshop is tailored to enhance your knowledge and skills in bioequivalence testing. 🔗 Register now to secure your spot and stay ahead in the dynamic field of bioequivalence! Got questions? Feel free to reach out or comment below. Let's advance together in the realm of bioequivalence studies! #Bioequivalence #Workshop

Deep dive into Quality by Design (QbD) with Evotec’s upcoming webinar: ‘Application of Design of Experiments in API Chemical Development’ Our API Research expert, Francesco Tinazzi, will explain the application of Design of Experiments (DoE) to chemical processes during API development, uncovering its advantages over traditional methods. Discover how DoE can be planned, with the identification of factors affecting the outputs, along with case studies that highlight the real-world benefits and applications of DoE in API development. Register now for the presentation and live Q&A, and discover the full series on QbD and DoE in drug development: https://hubs.ly/Q02tzwqJ0 #researchneverstops #drugdevelopment #QualityByDesign

Are you ready to learn about Protocol Management and why it is so crucial in Scientific Research and Drug Development? Tune in to my webinar tomorrow at 8 am Pacific.